Novartis AG - Total Cash From Operating Activities

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Cash-From-Operating-Activities" stands at 21.07 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Novartis AG's third quarter result of 6.57 Billion USD for the item "Total Cash From Operating Activities" represents a decrease of -1.40 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of 6.57 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 4.53 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of 21.07 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 1.37 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 31.64 percent compared to the value the year prior.
The 1 year change in percent is 31.64.
The 3 year change in percent is 50.42.
The 5 year change in percent is 59.83.
The 10 year change in percent is 62.79.

The Serie's long term average value is 14.14 Billion United States Dollars. It's latest available value, on 09/30/2025, is 49.07 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 09/30/2025, is +83.64%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.